LEADER 02429nam 22005414a 450 001 9910829908303321 005 20230721025910.0 010 $a1-280-82219-8 010 $a9786610822195 010 $a0-470-11312-X 010 $a0-470-11311-1 035 $a(CKB)1000000000354978 035 $a(EBL)287296 035 $a(SSID)ssj0000117272 035 $a(PQKBManifestationID)11129462 035 $a(PQKBTitleCode)TC0000117272 035 $a(PQKBWorkID)10043396 035 $a(PQKB)10336362 035 $a(MiAaPQ)EBC287296 035 $a(OCoLC)86267343 035 $a(EXLCZ)991000000000354978 100 $a20060802d2007 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aCancer biomarkers$b[electronic resource] $eanalytical techniques for discovery /$fMahmoud H. Hamdan 210 $aHoboken, N.J. $cWiley-Interscience$dc2007 215 $a1 online resource (405 p.) 225 1 $aWiley-Interscience series on mass spectrometry 300 $aDescription based upon print version of record. 311 $a0-471-74516-2 320 $aIncludes bibliographical references and index. 327 $aOverview -- Proteomic platforms for biomarkers discovery -- Some existing cancer biomarkers -- Potential cancer biomarkers -- Protein networks and protein phosphorylation in cancer -- Ethical issues and initiatives relevant to cancer biomarkers. 330 $aTools, techniques, and progress in cancer biomarkers discoveryThe completion of a number of gene sequencing projects, recent advances in genomic and proteomic technologies, and the availability of powerful bioinformatics tools have led to promising new avenues and approaches in the search for cancer biomarkers. This book provides a comprehensive overview of current methodologies and technologies. It discusses biomarker discovery as a whole, rather than focusing on one specific marker or cancer. With information on both existing and potential biomarkers, Cancer Biomarkers: Analytical Te 410 0$aWiley-Interscience series on mass spectrometry. 606 $aTumor markers 615 0$aTumor markers. 676 $a616.994075 700 $aHamdan$b Mahmoud$f1947-$01603761 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910829908303321 996 $aCancer biomarkers$94094932 997 $aUNINA